It could inhibit the proliferation of DLBCL cells via inhibiting activation of PI3K, mTORC1 and mTORC2 in both central B-cell (GCB) and activated B-cell (ABC) subtype of DLBCL[16]. Here, PIK3CD is linked to diffuse large B-cell lymphoma.